Regentis Biomaterials Ltd. RGNT
1.23 USD -0.02 (-1.60%)
At closeNov 13, 2026, 4:21 PM EST
1.23 0.00 0.00%
After hours · Nov 13, 4:21 PM ET
1.22 Day range 1.29
1.16 52-week range 15.50
- YTD
- -81.75%
- 1 year
- -83.60%
News
benzinga.com Regentis Biomaterials Strikes Distribution Deal With AMI Medical Technologies To Commercialize GelrinC In Israel Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced that it has entered into a
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Glaukos (NYSE:GKOS) shares rose 30.8% to $237.26 during Thursday's regular session. The company's market cap stands at $10.7 billion. The company's, Q3 earnings came out yesterday. Teladoc…- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers SciSparc (NASDAQ:SPRC) shares moved upwards by 39.4% to $1.52 during Monday's pre-market session. Xencor (NASDAQ:XNCR) stock moved upwards by 29.46% to $32.6. The company's market cap stands…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Greenland Mines (NASDAQ:GRML) stock rose 232.6% to $9.48 during Monday's regular session. The company's market cap stands at $9.0 million. GRAIL (NASDAQ:GRAL) shares moved upwards by 31.47%…
benzinga.com Regentis Biomaterials H1 EPS $(0.44) Up From $(1.17) YoY Regentis Biomaterials (AMEX:RGNT) reported quarterly losses of $(0.44) per share. This is a 62.39 percent increase over losses of $(1.17) per share from the same period last year.- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 49.1% to $4.1 during Tuesday's after-market session. The market value of their outstanding shares is at $1.5 million. CalciMedica (NASDAQ:CALC)…
benzinga.com Regentis Gets Japan Patent Office Notice of Allowance For Organic Solvent‑Free Protein‑Polymer Conjugate Compositions, Covering GelrinC Manufacturing Process And Ready‑to‑Use Liquid Formulation for Articular Cartilage Repair Patent expands intellectual property protection in one of the world's largest cartilage repair marketsGelrinC is a cell-free hydrogel delivered in a single ~10-minute procedure eliminating the need…
benzinga.com Regentis Biomaterials Receives European Regulatory Approval For New GelrinC Manufacturing Process The approval comes as Regentis prepares for the commercial launch of GelrinC® in Europe, enabling the Company to manufacture commercial product using a process that increases production yield by…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular session. The market value of their outstanding shares is at $7.8 million. Shuttle Pharmaceuticals…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular session. The company's market cap stands at $6.3 million. Regencell Bioscience (NASDAQ:RGC) stock moved…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Why Is Regentis Biomaterials Stock Rising On Wednesday? Regentis Biomaterials Ltd. (RGNT) stock rises after withdrawing its Form F-1 registration statement and accelerating European commercialization for GelrinC.
benzinga.com Why La-Z-Boy Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket Shares of La-Z-Boy Inc (NYSE: LZB) rose 19.6% in pre-market trading after reporting better-than-expected results and announcing a $300 million share buyback.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Why High Tide Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open. Other gainers include SLBT, TDIC, IMCC, IVDA, NXTS, CRVO, PAVS, ALBT, and PURR. Losers include…
benzinga.com Regentis Biomaterials Slips 9% After Soaring 506% On Monday — Here's Why RGNT Stock Is Trending Regentis stock surged 506% Monday after withdrawing its planned public offering, before slipping in after-hours trading.- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com Crude Oil Tumbles Over 5%; Empire State Manufacturing Index Falls In June US stocks gain on peace agreement with Iran, Nasdaq up 2%, Dow up 1.1%, S&P 500 up 1.54%. Tech shares jump 2.8%, energy stocks fall 3.5%. Empire State manufacturing index drops to 5.7. Industrial…
benzinga.com Regentis Biomaterials Withdraws F-1 Registration Statement And Cancels Planned Public Offering https://www.sec.gov/Archives/edgar/data/1912966/000121390026068601/ea0294796-6k_regentis.htm
benzinga.com Dow Jumps Over 600 Points Following US-Iran Peace Deal US stocks rise on peace agreement with Iran, Dow up 600 points. Tech sector jumps, energy stocks down. Trump announces deal, oil futures decline.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Why Nuvalent Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT, MTEN, NCRA, ZTG, EPSM, DBI, APLD. Losers include BYAH, NOTV.- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Why Sterling Infrastructure Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket Shares of Sterling Infrastructure Inc (NASDAQ: STRL) jumped 22.5% in pre-market trading after reporting better-than-expected Q1 results and raising its FY26 guidance. Other gainers include BLZE,…- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com Regentis Biomaterials Partners With Humanitas Research Hospital In Italy Over Expanding Clinical Activities In Europe Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced a collaboration with…
- benzinga.com Regentis Biomaterials Develops New Manufacturing Process For GelrinC, Off-The-Shelf Hydrogel Synchronized Erosion And Resorbable Implant For Treatment Of Painful Injuries To Focal Articular Knee Cartilage Breakthrough manufacturing process comes in preparation for upcoming commercial launch in Europe planned for later this yearProprietary process is already patented in several countries and is pending…
benzinga.com Regentis Biomaterials Names Ori Gon Chief Financial Officer And Chief Business Officer, As GelrinC Progresses In US Food and Drug Administration Phase III Trial GelrinC, the only restorative product for knee cartilage repair, has CE Mark approval in Europe and is currently at the midpoint of a pivotal FDA Phase III trial in the U.S.Ori Gon brings substantial…- benzinga.com Regentis Biomaterials GelrinC Demonstrates True Hyaline Cartilage Regeneration Two Years Post-Treatment In Long-Term Clinical Trial Data 2 years after treatment, GelrinC-treated patients demonstrated layered cartilage architecture similar to native hyaline cartilage - widely regarded as the gold standard for durable joint functionThis…
benzinga.com Regentis Biomaterials Publishes Data On Phase 2 Clinical Study Of GelrinC Regentis Biomaterials Ltd., ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced publication of long-term…- benzinga.com Regentis Biomaterials Secures Patent For Liquid, Ready-To-Use GerlinC Formulation, Enhancing Efficiency In Knee Cartilage Repair Patent protects ready to use liquid formulation of GerlinC which improves efficiency and focus for surgeons, resulting in a 10-minute procedureRobust IP portfolio includes 35 issued patents to date…
benzinga.com Regentis Biomaterials Ltd IPOs Tomorrow, Here's What You Need To Know 
benzinga.com Regentis Biomaterials Ltd To Start Trading Tomorrow - benzinga.com Preview: Regentis Biomaterials Ltd Set To IPO Tomorrow
- benzinga.com Regentis Biomaterials Ltd To Start Trading Tomorrow
benzinga.com Regentis Biomaterials Ltd To Start Trading Tomorrow